14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CHYM vs PWP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Perella Weinberg Partners (PWP) captures the overall head-to-head institutional edge over Chime Financial, Inc. (CHYM) on higher Unified Composite conviction (47.4/100 HOLD vs. 33.1/100 SELL) after splitting the core matrix 5–5 (led by Growth & Scale, Profitability & Quality), while CHYM wins 4–2 across the 6-pillar growth and valuation breakdown. CHYM trades at $34.25 (30.9x Forward P/E, 19.3% operating margin) versus PWP at $12.89 (8.8x Forward P/E, 8.6% operating margin).
Growth vs. Quality Trade-Off: PWP earns the overall head-to-head edge with a stronger Unified Composite Score (47.4/100 HOLD vs. CHYM 33.1/100 SELL) and 1.50β · 55% Vol risk profile, whereas CHYM leads top-line expansion (+32.1% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CHYM trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 73.7); meanwhile PWP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CHYM vs PWP. Trailing 12-month operating profitability (CHYM 19.3% vs PWP 8.6%) and valuation multiples (CHYM 30.9x vs PWP 8.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Capital Markets value chain with $1.4B market capitalization and 8.6% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CHYM vs PWP Key Questions & Quantitative Answers
As of Nov 16, 2026, Perella Weinberg Partners (PWP) captures the overall head-to-head institutional edge over Chime Financial, Inc. (CHYM) on higher Unified Composite conviction (47.4/100 HOLD vs. 33.1/100 SELL) after splitting the core matrix 5–5 (led by Growth & Scale, Profitability & Quality), while CHYM wins 4–2 across the 6-pillar growth and valuation breakdown. CHYM trades at $34.25 (30.9x Forward P/E, 19.3% operating margin) versus PWP at $12.89 (8.8x Forward P/E, 8.6% operating margin). Growth vs. Quality Trade-Off: PWP earns the overall head-to-head edge with a stronger Unified Composite Score (47.4/100 HOLD vs. CHYM 33.1/100 SELL) and 1.50β · 55% Vol risk profile, whereas CHYM leads top-line expansion (+32.1% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CHYM trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 73.7); meanwhile PWP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PWP leads the Growth & Scale pillar: CHYM posts +32.1% YoY revenue growth and -33.8% YoY earnings growth on $14.3B TTM revenue (89.4% gross margin, 19.3% operating margin), compared with PWP at +52.7% YoY revenue growth and +153.4% YoY earnings growth on $776M TTM revenue (97.1% gross margin, 8.6% operating margin). On trailing 12-month operating scale, CHYM generates $14.3B in USD-normalized revenue versus $776M for PWP. In operating R&D and SG&A reinvestment, CHYM deploys 70.1% of Rev ($10.1B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PWP.
CHYM screens cheaper on headline valuation multiples. CHYM trades at 30.9x Forward P/E, 29.0x Trailing P/E, N/M PEG, and 0.7x EV/Revenue (15.8% FCF margin), whereas PWP trades at 8.8x Forward P/E, 34.5x Trailing P/E, N/M PEG, and 1.8x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CHYM (5.4% ROE) versus PWP (15.2% ROE) capital efficiency.
In options market volatility and institutional positioning, CHYM carries 48.7% implied volatility (12th %ile, Compressed (<25th %ile)), a 0.22x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.44β · 37% Vol realized risk). By comparison, PWP carries 66.2% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.50β · 55% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.